Immunophenotipic analyses (percentages of cells) in 2 groups of newborns
| Marker . | SR (n = 20) . | UC (n = 14) . | Statistical significance (P value) . |
|---|---|---|---|
| CD4 | 52.1 ± 4.9 | 59 ± 4.6 | .069 |
| CD8 | 22.1 ± 5.0 | 16.1 ± 3.4 | < .0001 |
| CD4/CD8 ratio | 2.7 ± 1.1 | 3.8 ± 0.9 | .00015 |
| CD4/RA/62 | 74.7 ± 8.9 | 89.7 ± 3.7 | < .0001 |
| CD4/RO | 24.9 ± 9.6 | 10.3 ± 3.3 | < .0001 |
| CD8/RA/LFAlow | 58.9 ± 15.3 | 77.7 ± 3.8 | .0033 |
| CD8/RA/LFAhigh | 22.1 ± 4.3 | 9.6 ± 4.1 | .0027 |
| CD8/38dim | 49.3 ± 13.9 | 79.7 ± 3.1 | < .0001 |
| CD8/38bright | 24.2 ± 11.1 | 1.8 ± 1.3 | <.0001 |
| CD3 DN | 9.3 ± 2.6 | 3.3 ± 1.1 | < .0001 |
| CD3 DN/44 | 8.8 ± 2.7 | 3.1 ± 0.9 | <.0001 |
| Marker . | SR (n = 20) . | UC (n = 14) . | Statistical significance (P value) . |
|---|---|---|---|
| CD4 | 52.1 ± 4.9 | 59 ± 4.6 | .069 |
| CD8 | 22.1 ± 5.0 | 16.1 ± 3.4 | < .0001 |
| CD4/CD8 ratio | 2.7 ± 1.1 | 3.8 ± 0.9 | .00015 |
| CD4/RA/62 | 74.7 ± 8.9 | 89.7 ± 3.7 | < .0001 |
| CD4/RO | 24.9 ± 9.6 | 10.3 ± 3.3 | < .0001 |
| CD8/RA/LFAlow | 58.9 ± 15.3 | 77.7 ± 3.8 | .0033 |
| CD8/RA/LFAhigh | 22.1 ± 4.3 | 9.6 ± 4.1 | .0027 |
| CD8/38dim | 49.3 ± 13.9 | 79.7 ± 3.1 | < .0001 |
| CD8/38bright | 24.2 ± 11.1 | 1.8 ± 1.3 | <.0001 |
| CD3 DN | 9.3 ± 2.6 | 3.3 ± 1.1 | < .0001 |
| CD3 DN/44 | 8.8 ± 2.7 | 3.1 ± 0.9 | <.0001 |
SR = healthy HIV-uninfected children of HIV-infected mothers (seroreverters); UC = healthy children of HIV-negative women (uninfected controls); DN = double negatives; LFA = leukocyte function-associated antigen.
Mean values ± standard deviations are shown.